J Gynecol Oncol.  2008 Dec;19(4):218-222. 10.3802/jgo.2008.19.4.218.

Gynecologic oncology group trials in uterine corpus malignancies: recent progress

• Miller DS
• King LP

• KMID: 2173409
• DOI: http://doi.org/10.3802/jgo.2008.19.4.218

Abstract

The Gynecologic Oncology Group (GOG) has conducted multiple trials related to malignancies of the uterine corpus. Recently, several of these trials have been presented and/or published. Areas of focus included the feasibility of laparoscopic staging for endometrial cancer, the adjuvant management of locally advanced endometrial cancer, whole abdominal irradiation in maximally resected advanced endometrial carcinoma, and combination chemotherapy regimens for stage I and II carcinosarcoma after primary surgery and for advanced or recurrent carcinosarcoma. This article will discuss the background and details of each of these important advances.

Keyword

Endometrial neoplasm; Carcinosarcoma; Clinical trial

MeSH Terms

Carcinosarcoma
Drug Therapy, Combination
Endometrial Neoplasms
Female

Figure

• 

  Fig. 1 A phase III randomized clinical trial of laparoscopic pelvic and para-aortic node sampling with vaginal hysterectomy and BSO versus open laparotomy with pelvic and para-aortic node sampling and abdominal hysterectomy and BSO in endometrial adenocarcinoma and uterine sarcoma, clinical stage I, IIA, Grade I, II, III.

• 

  Fig. 2 Whole abdominal radiotherapy versus combination doxorubicin-cisplatin chemotherapy in advanced endometrial carcinoma (phase III).

• 

  Fig. 3 A randomized phase III study of tumor volume directed pelvic plus or minus para-aortic irradiation followed by cisplatin and doxorubicin or cisplatin, doxorubicin and paclitaxel for advanced endometrial carcinoma.

• 

  Fig. 4 A phase III randomized study of whole abdominal radiotherapy versus combination ifosfamide-mesna with cisplatin in optimally debulked stage I, II, III or IV carcinosarcoma of the uterus.

• 

  Fig. 5 A phase III trial of ifosfamide versus ifosfamide plus paclitaxel in patients with advanced, persistent, or recurrent carcinosarcoma (mixed mesodermal tumors) of the uterus.

Reference

1. Spirtos NM, Eisenkop SM, Boike G, Schlaerth JB, Cappellari JO. Laparoscopic staging in patients with incompletely staged cancers of the uterus, ovary, fallopian tube, and primary peritoneum: a Gynecologic Oncology Group (GOG) study. Am J Obstet Gynecol. 2005. 193:1645–1649.

2. Walker L, Piedmonte M, Spirtos N, Eisenkop S, Schlaerth J, Mannel RS, et al. Surgical staging of uterine cancer: randomized phase III trial of laparoscopy versus laparotomy - A Gynecologic Oncology Study (GOG): Preliminary results [abstract]. J Clin Oncol. 2006. 24(18S):5010.

3. Walker L, Mannel R, Piedmonte M, Schlaerth J, Spirtos N, Spiegel G. Phase III trial of laparoscopy (scope) vs laparotomy (open) for surgical resection and comprehensive surgical staging of uterine cancer: A Gynecologic Oncology Group (GOG) study funded by NCI [abstract]. Gynecol Oncol. 2006. 101:S11–S12.

4. Sutton G, Axelrod JH, Bundy BN, Roy T, Homesley HD, Malfetano JH, et al. Whole abdominal radiotherapy in the adjuvant treatment of patients with stage III and IV endometrial cancer: a gynecologic oncology group study. Gynecol Oncol. 2005. 97:755–763.

5. Thigpen JT, Brady MF, Homesley HD, Malfetano J, Dubeshter B, Burger RA, et al. Phase III trial of doxorubicin with or without cisplatin in advanced endometrial carcinoma: a gynecologic oncology group study. J Clin Oncol. 2004. 22:3902–3908.

6. Randall ME, Filiaci VL, Muss H, Spirtos NM, Mannel RS, Fowler J, et al. Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a Gynecologic Oncology Group Study. J Clin Oncol. 2006. 24:36–44.

7. Bruner DW, Barsevick A, Tian C, Randall M, Mannel R, Cohn DE, et al. Randomized trial results of quality of life comparing whole abdominal irradiation and combination chemotherapy in advanced endometrial carcinoma: a gynecologic oncology group study. Qual Life Res. 2007. 16:89–100.

8. Homesley HD, Filiaci V, Gibbons SK, Long HJ, Spirtos NM, Morris RT, et al. Randomized phase III trial in advanced endometrial carcinoma of surgery and volume-directed radiation followed by cisplatin and doxorubicin with or without paclitaxel [abstract]. Gynecol Oncol. 2008. 108:S2.

9. Sutton G, Brunetto VL, Kilgore L, Soper JT, McGehee R, Olt G, et al. A phase III trial of ifosfamide with or without cisplatin in carcinosarcoma of the uterus: a Gynecologic Oncology Group Study. Gynecol Oncol. 2000. 79:147–153.

10. Sutton G, Kauderer J, Carson LF, Lentz SS, Whitney CW, Gallion H. Adjuvant ifosfamide and cisplatin in patients with completely resected stage I or II carcinosarcomas (mixed mesodermal tumors) of the uterus: a Gynecologic Oncology Group study. Gynecol Oncol. 2005. 96:630–634.

11. Wolfson AH, Brady MF, Rocereto T, Mannel RS, Lee YC, Futoran RJ, et al. A gynecologic oncology group randomized phase III trial of whole abdominal irradiation (WAI) vs. cisplatin-ifosfamide and mesna (CIM) as post-surgical therapy in stage I-IV carcinosarcoma (CS) of the uterus. Gynecol Oncol. 2007. 107:177–185.

12. Homesley HD, Filiaci V, Markman M, Bitterman P, Eaton L, Kilgore LC, et al. Phase III trial of ifosfamide with or without paclitaxel in advanced uterine carcinosarcoma: a Gynecologic Oncology Group Study. J Clin Oncol. 2007. 25:526–531.